drugset / Trial / NCT02541526
Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate tolerability, acceptability and potential efficacy of 4 months of maintenance treatment with Mirtazapine as compared to placebo for patients with co-occurring amphetamine-type stimulant and opioid dependence (COATS) receiving buprenorphine maintenance treatment (BMT) in Kota Bharu.
Timeline
- Start
- 2013-05
- Primary completion
- 2017-01
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | 30 mg | Oral |